<DOC>
	<DOCNO>NCT00673452</DOCNO>
	<brief_summary>The purpose study confirm efficacy safety duloxetine 60-120 mg daily comparison placebo symptom improvement patient meet criterion fibromyalgia age 18 old . Patients randomized duloxetine placebo , however , patient receive duloxetine point study .</brief_summary>
	<brief_title>A Study Comparing Duloxetine Placebo Treatment Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>male female patient age 18 old meet criterion fibromyalgia defined American College Rheumatology score least 4 average pain item Brief Pain Inventory ( BPI ) ( modify short form ) visit 1 2 female must test negative pregnancy time enrollment degree understand patient provide inform consent , complete protocol require assessment communicate intelligibly investigator study coordinator . pain symptom relate traumatic injury , structural rheumatic disease , regional rheumatic disease interfere interpretation outcome measure regional pain syndrome , multiple surgery fail back syndrome confirm current previous diagnosis rheumatoid arthritis , inflammatory arthritis , infectious arthritis , autoimmune disease ( i.e . systemic lupus erythematosus )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>